Don't wait lose weight with NutriSystem pasta
Showing posts with label educational. Show all posts
Showing posts with label educational. Show all posts

Tuesday, May 19, 2009

New Educational Tool for Understanding UC Flares

Ulcerative colitis (UC) is a chronic, inflammatory bowel disease (IBD) affecting half a million people in the United States, yet many patients don't always understand how to recognize or treat the symptoms associated with the disease.

Ulcerative colitis is an inflammation of the lining of the rectum and colon. The disease is marked by unpredictable "flares" when the inflammation causing the disease state spikes, causing stomach pain and bloody diarrhea. Up to 80 percent of UC patients suffer from flares. This highlights the need for patient, physician, and caregiver information.(1)

To provide that information, an educational brochure titled, Managing Flares and other IBD Symptoms, is now available from the Crohn's and Colitis Foundation of America (CCFA), made possible by an educational grant from Alaven Pharmaceutical LLC, makers of the topical UC flare treatment, ROWASA Kit* (mesalamine rectal suspension enema).

The brochure further defines the symptoms of flare-ups for both Crohn's** disease and UC and includes information on diet and lifestyle, the treatment options for overall maintenance of the diseases and flares specifically, questions patients should ask their doctor when flares occur and a flare symptom tracker.(2)

"We've learned from patients and physicians that there is a need for outreach about what people living with inflammatory bowel diseases should know about flares," said Dave Riccio, Product Manager, Alaven Pharmaceutical. "Working with the CCFA to provide patients with another tool to fight against UC flares will help educate them on how to effectively manage their disease and treat unwanted flare symptoms when they strike."

Gastroenterologists interested in providing the flare brochure to UC patients may request copies at www.flarefighter.com.

The brochure will also be made available to CCFA patient chapters across the country and can be downloaded at www.ccfa.org or via www.RowasaKit.com. Patients experiencing flares and who would like additional support services may also visit the CCFA's community website at www.ccfacommunity.org.

ROWASA is indicated for the treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis, or proctitis.

Full Prescribing Information available: www.ROWASAKit.com.

*Wipe is optional and not a required part of treatment

**ROWASA is not indicated for the treatment of Crohn's Disease.


(1) Tindall WN, Boltri JM, Wihelm SM. Mild-to-Moderate Ulcerative Colitis: Your role in patient compliance and health care costs. JMCP. 2007;13(7): S1-S15.

(2) Managing Flares and Other IBD Symptoms. CCFA. April 2009.

-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page
www.artsacrossgeorgia.com
Arts Across Georgia

Friday, March 06, 2009

March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are?

/PRNewswire/ -- Colorectal cancer, also referred to as colon cancer, is one of the most preventable cancers. Recent statistics show that the incidence (the rate at which new cancers are diagnosed) and death rates from colorectal cancer are declining, in part due to prevention through screening and removal of precancerous polyps (growths in the colon that can turn into cancer). Colorectal cancer screening has been in the news a lot in the past few months, from studies about new technologies to updated screening recommendations; patients may be left wondering which screening method is best for them. March is National Colorectal Cancer Awareness Month and this year the American Society for Gastrointestinal Endoscopy (ASGE), which represents the specialists in colorectal cancer screening, is educating patients about the recommended screening methods.

"The good news is that death rates are declining from colorectal cancer. The bad news is that only about half of those who should be screened are doing so," said John L. Petrini, MD, FASGE, president of the American Society for Gastrointestinal Endoscopy. "Age is the most important risk factor for colorectal cancer. ASGE guidelines recommend screening begin at age 50 for men and women at average risk who have no symptoms. Some people may need to be screened earlier if there is a family history of the disease. It's important to talk to your doctor about an appropriate screening schedule. Ask questions and work with your doctor to determine the screening method that is best for you, as each screening option has appropriate applications and limitations."

To learn more about colorectal cancer prevention, log on to the ASGE's colorectal cancer awareness Web site www.screen4coloncancer.org. Screen4coloncancer.org offers visitors a wealth of vital information including disease facts about colorectal cancer, screening options, what to expect during a colonoscopy, frequently asked questions, the latest news about colorectal cancer such as studies and statistics, links to patient support and advocacy groups, educational videos, and how to find a qualified doctor in your area. The content is available in English, Spanish and Chinese. In addition to these features, is the Peter and Polly Polyp(TM) birthday e-Card encouraging the recipient to get screened for colorectal cancer.

New this year to www.screen4coloncancer.org is a patient education video on colonoscopy. This informative video walks patients through what they need to know before, during and after a colonoscopy.

About Colorectal Cancer

Colorectal cancer is cancer that develops in the colon (large intestine) or the rectum, and usually develops slowly over a period of many years. Before a true cancer develops, it usually begins as a non-cancerous polyp, which may eventually change into cancer. A polyp is a growth of tissue that develops on the lining of the colon or rectum. Certain kinds of polyps, called adenomas, are most likely to become cancerous. The only screening method that allows for the removal of polyps BEFORE cancer develops is colonoscopy.

All men and women over the age of 50 should be routinely screened for colorectal cancer. Colorectal cancer is a preventable and highly treatable cancer when caught at an early stage. Routine screening can save lives. ASGE screening guidelines recommend that, beginning at age 50, men and women with no symptoms who are at average risk for developing colorectal cancer should have a colonoscopy every 10 years. Colorectal cancer is the third most commonly diagnosed cancer and the third leading cause of cancer death in both men and women in the United States, with nearly 150,000 new cases diagnosed each year. Approximately 50,000 people die from it annually.

Although colorectal cancer often has no symptoms, warning signs that may indicate colorectal cancer include blood in your stools, narrower than normal stools, unexplained abdominal pain, unexplained change in bowel habits, unexplained anemia, and unexplained weight loss. These symptoms may be caused by other benign diseases such as hemorrhoids, inflammation in the colon or irritable bowel syndrome. However, if you have any of these symptoms, you should be evaluated by your doctor.

To assist the public in understanding the different screening options available, the ASGE has developed a list summarizing recommended screening methods.

Screening is done on individuals who do not necessarily have any signs or symptoms that may indicate cancer. If symptoms exist, then diagnostic workups are done rather than screening.

Stool blood test (fecal occult blood test or FOBT):

This test is used to find small amounts of hidden (occult) blood in the stool. A sample of stool is tested for traces of blood. People having this test will receive a kit with instructions that explain how to take stool samples at home. The kit is then sent to a lab for testing. If the test is positive, further tests will be done to pinpoint the exact cause of the bleeding. A rectal exam in the doctor's office may examine for occult blood, but this is NOT considered adequate for colorectal cancer screening. The test should only be done with a take-home kit.

A newer kind of stool blood test is known as FIT (fecal immunochemical test). It is like the FOBT, perhaps even easier to do, and it gives fewer false positive results.

PROS:
-- Simple
-- Cost-effective
-- Done at home

CONS:
-- Must be done yearly
-- Least effective means of detecting cancer
-- Viewed as unsanitary by some
-- Patient must retrieve samples of stool in the toilet bowl
-- All positive results must be evaluated with a colonoscopy

Flexible sigmoidoscopy (flex-sig):

A sigmoidoscope is a slender, lighted tube about the thickness of a finger. It is placed into the lower part of the colon through the rectum. This allows the physician to look at the inside of the rectum and lower part of the colon for cancer or polyps. This exam only evaluates about one third of the colon. The test is often done without any sedation, so it can be uncomfortable, but it should not be painful. Before the test, you will need to take an enema or other prep to clean out the lower colon.

PROS:
-- Quick -- usually a one-to-five minute exam
-- Does not require as vigorous a bowel prep as some other methods
-- Does not require sedation

CONS:
-- Can only examine the lower third of the colon, the other two-thirds of
the colon are not examined
-- If polyps are found, the patient must return for a full colonoscopy

Colonoscopy:

Colonoscopy allows for a complete evaluation of the colon and removal of potentially precancerous polyps. It is the only colorectal cancer screening tool that is both diagnostic and therapeutic. A complete bowel cleansing is required before the exam. The procedure uses a colonoscope, a thin, flexible tube with a light and video camera on the end that transmits images to a TV screen that allows the doctor to see inside the entire colon. If a polyp is found, the doctor can remove it immediately. The polyp is usually removed with small biopsy forceps or loop of wire (snare) that is advanced within a channel in the colonoscope. The polyp is then sent to a lab where a doctor called a pathologist looks at it under a microscope for analysis. If anything else looks abnormal, a biopsy (tissue sample) might be done. To do this, biopsy forceps are placed in the colonoscope and a small piece of tissue is removed. The tissue is sent to the lab for evaluation. Colonoscopy is typically done with sedation and is well-tolerated. You will be given medicine that is injected through a vein to make you feel relaxed and sleepy.

PROS:
-- Examines the entire colon, making this the most thorough method for
evaluating the colon and rectum
-- High detection rate for polyps, including small polyps, and ability to
remove them immediately during the procedure
-- Typically done with intravenous sedation to assure comfort during the
exam
-- Given the "Gold Standard" rating above all other screening options by:
American Society for Gastrointestinal Endoscopy (ASGE), American
Gastroenterological Association (AGA), American College of
Gastroenterology (ACG), the American Cancer Society (ACS), and the
American College of Obstetricians and Gynecologists (ACOG).

CONS:
-- Requires a complete bowel prep the night before to cleanse the colon
-- Unexpected events or complications are rare, but do occur and may
include:
-- Missing a lesion
-- Making a tear in the lining of the colon, which is called
perforation
-- Bleeding
-- A bad reaction to the medication used for sedation

Barium enema with air contrast:

A chalky substance, which shows up on X-ray, is given as an enema. Air is then pumped into the colon causing it to expand. This allows X-ray films to take pictures of the colon. Laxatives must be used the night before the exam to clean the colon.

PROS:
-- Done without sedation
-- Very low risk

CONS:
-- Uses X-ray radiation
-- Can miss larger polyps and growths (over 50 percent polyps 1 cm, and
15 percent of cancers)
-- If polyps are found, the patient must be followed up with a
colonoscopy


CT COLONOGRAPHY (also referred to as virtual colonoscopy) A small tube is placed in the rectum and air is pumped into the colon to inflate the bowel. Then a special CT scan is used to image the colon. Recent studies show that it is effective in identifying medium to large polyps, but is ineffective in identifying small polyps. CT colonography may be best for low-risk patients who cannot undergo colonoscopy or who have had an incomplete colonoscopy due to various factors. The same bowel prep as conventional colonoscopy is required and it does not use sedation.

PROS:
-- Examines the entire colon
-- High detection rate for medium to large polyps
-- Low risk

CONS:
-- Air distention of the bowel can be uncomfortable
-- Ineffective in detection of small polyps
-- Uses X-ray radiation
-- If polyps or other abnormalities are found, a colonoscopy must be
performed
-- Is not covered by Medicare as an initial screening test
-- Is not recommended by ASGE screening guidelines or the U.S. Preventive
Services Task Force (USPSTF) recommendations


Check with your insurance provider or the Centers for Medicare and Medicaid Services regarding which screening methods are a covered benefit.

-----
www.georgiafrontpage.com
Georgia Front Page
www.fayettefrontpage.com
Fayette Front Page

Sunday, January 25, 2009

New Survey Highlights People with Parkinson’s and Caregivers’ Needs

(ARA) - In the United States, nearly one million people are affected by Parkinson’s disease, with one person diagnosed every nine minutes. That means that in the time it takes you to boil pasta, make a pot of coffee, or write a quick e-mail, one more person has been diagnosed.

Although many Americans are affected by this devastating disease, a new survey unveiled a need for increased education on key issues in the management of Parkinson’s disease. The “Parkinson’s Knowledge and Needs Exchange" survey was commissioned and funded by Boehringer Ingelheim Pharmaceuticals, Inc. GfK Roper Public Affairs & Media designed and conducted the survey on behalf of Boehringer Ingelheim Pharmaceuticals, Inc., in collaboration with the Parkinson’s Disease Foundation.

This survey is the first of its kind in a decade to explore the dynamics between people living with the disease, their caregivers and the neurologists who treat them. Key findings reveal a great need for the development of resources that can improve disease management, as well as the opportunity to educate people of existing resources. Some of these resources include support groups, educational Web sites and information available through physicians.

Communication is one of the key barriers to optimal disease management for the community.

While people living with Parkinson’s disease and their caregivers take an active role in discussions with their doctor, survey findings reveal a need for resources and tools to help enhance the quality of communication during doctor’s office visits. In fact, nine out of 10 people with Parkinson’s disease surveyed, would find a discussion guide with sample questions for the doctor to be a useful resource and 87 percent of caregivers agree. The survey also found that unless the patient and/or caregiver brought up particular issues, neurologists did not discuss them because they were concerned with overwhelming the patient and/or caregiver (59 percent of neurologists surveyed reported this).

Although the disease generally progresses slowly, over time even the most basic daily routines, like socializing with friends and family members, earning a living, and taking care of the home, may be affected. When asked, a majority of neurologists felt that financial concerns are the greatest obstacle for caregivers, and yet, this topic was only discussed with 35 percent of caregivers. Further, more than half of caregivers surveyed would like their physician to discuss the financial or legal impact more often during their disease management discussions. In addition, nearly one in four neurologists does not discuss healthy lifestyle changes with people living with Parkinson’s disease or caregivers, despite nearly all physicians (85 percent) thinking that maintaining a healthy lifestyle is an obstacle for both groups. Recent studies have shown that stretching, strengthening, and balance training may improve gait, speed, balance, and participation in activities of daily living, and regular exercise can help people with PD stay more flexible, improve posture, and make overall movement easier.

Education in and out of the doctor’s office.

It is important that people living with Parkinson’s and their caregivers continue to educate themselves and are able to find appropriate answers to their questions easily and effectively. In today’s fast paced, technology-based society, it’s easy to quickly become overwhelmed in a quest for answers. In fact, more than three-fourths of neurologists’ patients and caregivers state that a single resource would be helpful in disease management.

Resources that support people with Parkinson’s disease and their caregivers are available, and yet, more than half of all caregivers and patients surveyed are not taking advantage of the tools provided by patient advocacy groups and educational Web sites.

Support groups, educational Web sites and resources available through physicians can offer helpful advice on:
* Exercise: 92 percent of people living with Parkinson’s disease would be interested in a form of exercise designed for people with the disease
* Making a home Parkinson’s disease friendly: 84 percent of people with Parkinson’s disease and 81 percent of caregivers expressed interest in this topic
* Parkinson’s clinical studies: 63 percent of people living with Parkinson’s disease and 70 percent of caregivers said information from a Parkinson’s organization would motivate them to join a clinical trial. For more information please visit clinicaltrials.gov.

Also, the Parkinson’s Disease Foundation developed the Parkinson’s Information Service (PINS), a unique toll-free/online service, which connects people with questions about Parkinson’s disease to trained PDF information specialists.

Parkinson’s disease is a potentially debilitating neurological condition, impacting movement. The average age of a person diagnosed with the disease is 60. It is the second most common chronic neurological disorder in older adults after Alzheimer’s. Symptoms include tremor, muscle rigidity, slowed motion, shuffling gait, and a loss of facial expression. The symptoms vary from individual to individual, but become more severe over time. While promising research is being conducted, there is currently no cure for Parkinson’s disease.

Although there are obstacles and educational barriers within the Parkinson’s community, there are educational tools and resources, and future materials to support patients, caregivers and physicians. There are great opportunities to increase collaboration and begin overcoming some challenges and better manage this disease.

Courtesy of ARAcontent

-----
www.fayettefrontpage.com
Fayette Front Page
Community News You Can Use
Fayetteville, Peachtree City, Tyrone
www.georgiafrontpage.com
Georgia Front Page

Monday, October 27, 2008

How Well Do You Know Your Pharmacist?

(NAPSI)-Have you ever had a question about cold, sinus or allergy medicines in front of or behind the pharmacy counter, but weren't sure if you should ask your pharmacist? Or, have you ever wondered what goes on behind the pharmacy counter? According to a recent survey, when it comes to their pharmacist, consumers are definitely not "in the know."

Unlocking The Mystery Of Behind-the-Counter

The truth is that pharmacists are trusted advisors on your healthcare team who have the expertise and training to help people who have questions access the medicine that is right for them. Many times, pharmacists can be the first point-of-contact for patients with health inquiries and they work hard every day to help people with their healthcare questions.

"Especially with cold and flu season rapidly approaching, it's important for people to know that, if they have questions, pharmacists can provide helpful information about medicines located in front of or behind-the-counter that are available without a prescription," says Kristen Binaso, RPh, CCP, FASCP, of the American Pharmacists Association.

To help highlight the importance of pharmacists, the APhA is teaming with comedian Brad Sherwood, best-known as a cast member of the Emmy-nominated TV show "Whose Line Is It Anyway?",* to launch the Behind-the-Counter Encounters campaign. This educational campaign aims to raise awareness about the role of your local pharmacist.

Sherwood stars with pharmacists in a series of online videos that portray a "day in the life" of a pharmacist. The APhA and Sherwood encourage people to visit www.BTCcenter.com to view the videos and to learn more about the campaign. The campaign was created with support from McNeil Consumer Healthcare, a division of McNEIL-PPC, Inc.

*Property of the following: Warner Brothers, Television and ABC Family.

-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page